Skip to main content

Find Clinical Trials

Home
Conditions
Liver Transplantation

Clinical trial condition

Liver Transplantation

Explore clinical trials studying Liver Transplantation. Study availability and eligibility vary by location and protocol.

270 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

Liver Transplantation trial results

Completed

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

NCT00722332

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Los Angeles, California, United States

Los Angeles, California, United States

Palo Alto, California, United States

Atlanta, Georgia, United States

View all 16 locations

View Trial Details

Completed

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

NCT00282256

Conditions: Liver Transplantation
Locations: Atlanta, Georgia, United States

Indianapolis, Indiana, United States

New Orleans, Louisiana, United States

New York, United States

View Trial Details

Completed

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

NCT00282243

Conditions: Liver Transplantation
Locations: Palo Alto, California, United States

Denver, Colorado, United States

Baltimore, Maryland, United States

Ann Arbor, Michigan, United States

View Trial Details

Completed

Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients

NCT00622869

Conditions: Liver Transplantation
Locations: Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site Los Angeles, California, United States

Novartis Investigative Site San Francisco, California, United States

View all 91 locations

View Trial Details

Completed

Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

NCT00456235

Conditions: Liver Transplantation
Locations: CHU de Besançon Besançon, France

CHU de Bordeaux Bordeaux, France

CHU de Caen Caen, France

Hôpital Beaujon Clichy, France

View all 17 locations

View Trial Details

Completed

Effect of Rapid Transfusion With Fluid Management System 2000® (FMS)

NCT01448343

Conditions: Liver Transplantation
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

NCT00295607

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Prague, Czechia

Besançon, France

Lyon, France

Nice, France

View all 17 locations

View Trial Details

Completed

The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient

NCT01457534

Conditions: Liver Transplantation
Locations: Severance Hospital Seoul, South Korea

View Trial Details

Completed

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

NCT00105235

Conditions: Behavior, Digestive System Diseases, Liver Disease, +4 more
Locations: University of California, San Francisco San Francisco, California, United States

University of Colorado Denver, Colorado, United States

University of Miami School of Medicine Miami, Florida, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation

NCT00080236

Conditions: Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +13 more
Locations: Mayo Clinic Scottsdale Phoenix, Arizona, United States

University of California Los Angeles Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

Indiana University Medical Center Indianapolis, Indiana, United States

View all 13 locations

View Trial Details